Saba Capital Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-965,348
| Closed | -$9.75M | – | 936 |
|
|
2022
Q4 | $9.75M | Hold |
965,348
| – | – | 0.13% | 241 |
|
|
2022
Q3 | $9.58M | Buy |
965,348
+60,405
| +7% | +$600K | 0.11% | 327 |
|
|
2022
Q2 | $8.96M | Hold |
904,943
| – | – | 0.1% | 344 |
|
|
2022
Q1 | $8.92M | Hold |
904,943
| – | – | 0.13% | 269 |
|
|
2021
Q4 | $8.91M | Hold |
904,943
| – | – | 0.13% | 213 |
|
|
2021
Q3 | $8.81M | Buy |
904,943
+315,057
| +53% | +$3.07M | 0.22% | 106 |
|
|
2021
Q2 | $5.7M | Buy |
+589,886
| New | +$5.7M | 0.16% | 128 |
|